Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Coadministration of RSV and Tdap Vaccines

Evidence Supporting Coadministration

  • Inactivated vaccines like RSV and Tdap may be administered concomitantly with, or at any time before or after, other inactivated vaccines, according to the Journal of Microbiology, Immunology and Infection guidelines 1
  • The American Society of Clinical Oncology guideline explicitly notes that coadministration of two or more recommended nonlive vaccines is acceptable, and when given on separate days, there is no recommended waiting period 2
  • Multiple major guidelines confirm that inactivated vaccines do not interfere with immune responses to other inactivated vaccines, as stated in the Journal of Microbiology, Immunology and Infection 1

Practical Administration Guidelines

  • Each vaccine should be administered using a separate syringe at a different anatomic site, as recommended by Praxis Medical Insights 3
  • Minor illnesses without fever are not contraindications for vaccination, according to Praxis Medical Insights 3
  • Patients with stable neurologic disorders or immunosuppression can still receive both vaccines, though immune responses may be suboptimal in immunocompromised individuals, as stated in the MMWR Recommendations and Reports 4

Special Considerations

  • A 15-20 minute observation period following vaccination is recommended, as syncope can occur after vaccination and may be more common among adolescents and young adults, according to Praxis Medical Insights 3